Patent · US Active

7-azaindole derivatives

US8466170B2 · kind B2 · utility

23Cited by

0References

26Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventor

Markus Klein · Weiterstadt, DE

Key dates

Filing date	Jul 10, 2009
Grant date	Jun 18, 2013
Priority date	—
Expiry date	Dec 10, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel 7-azaindole derivatives of the formula (I), in which U, L, R, Y, X1, X2 and X3 have the meanings indicated in Claim (1), are kinase inhibitors and can be used for the treatment of diseases and conditions such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in any type of fibroses, inflammatory processes, tumors and tumor diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.